样式: 排序: IF: - GO 导出 标记为已读
-
Improvements in patient-reported outcomes with oral roflumilast for psoriasis: Results from a randomized controlled trial (PSORRO). J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-09-19 Mette Gyldenløve,Jennifer Astrup Sørensen,Simon Francis Thomsen,Simon Fage,Lars Iversen,Lone Skov,Claus Zachariae,Alexander Egeberg,Mia-Louise Nielsen
-
Effectiveness and safety of methotrexate in the treatment of mycosis fungoides: Real-world data from a multicentre study. J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-09-19 Vasiliki Nikolaou,Evdoxia Panou,Antonios Tsimpidakis,Ioannis-Alexios Koumprentziotis,Aikaterini Patsatsi,Marina Siakantaris,Sabine-Elke Kruger-Krasagakis,Leonidas Marinos,Elisavet Georgiou,Kyriaki Lampadaki,Aliki Velissari,Athina-Ioanna Daponte,Aikaterini Doxastaki,Stella Kaliampou,Aristeidis Vaiopoulos,Iliana Konstandinou,Marios Koumourtzis,Eleftheria Lakiotaki,Vassiliki Pappa,Athanasios Tsamaldoupis
BACKGROUND Methotrexate (MTX) has been a longstanding therapeutic option for mycosis fungoides (MF); however, data on its real-world effectiveness remain limited. OBJECTIVES To evaluate treatment-related outcomes of oral MTX in patients with early- and late-stage MF. METHODS This is a retrospective multicentre analysis involving MF subjects from five referral centres for cutaneous lymphomas in Greece
-
Bullous pemphigoid burden of disease, management and unmet therapeutic needs. J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-09-19 V P Werth,D F Murrell,P Joly,M Ardeleanu,V Hultsch
Bullous pemphigoid (BP) is an autoimmune blistering disease that can have a profound negative impact on quality of life. BP most often affects the elderly, a population with a high medical burden and special safety concerns. In this review, we outline the BP disease course, diagnosis, epidemiology and comorbidities, and describe tools commonly used to assess BP disease activity and severity and the
-
Single‐centre experience with tralokinumab in dupilumab‐experienced and naïve patients with atopic dermatitis J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-09-18 Claire Fossati, Emmanuella Guenova, Curdin Conrad, Michel Gilliet, Teofila Seremet
-
A cluster of early syphilis cases with ocular manifestations on the island of Crete J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-09-18 Dimitra Koumaki, Georgios Evangelou, Faidra Marazaki, Danae Petrou, Maria Gorgomiti, Stamatios Gregoriou, Petros Ioannou, Vasiliki Koumaki, Efstathios T. Detorakis, Aikaterini Chalkia, Maria Vavouranaki, Konstantinos Krasagakis
-
Low‐dose oral minoxidil for the treatment of monilethrix: A retrospective review J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-09-18 Emadodin Darchini‐Maragheh, Anthony Moussa, Dmitri Wall, Nekma Meah, Rodney Sinclair
-
Educational, labour market and relationship outcomes in people with acne J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-09-18 John S. Barbieri, Dóra K. Farkas, Niels Skipper, Ketaki Bhate, Sinéad M. Langan, Line Kibsgaard, Henrik T. Sørensen, Sigrun A. J. Schmidt
BackgroundAlthough acne is associated with scarring, mental health comorbidities and bullying, little is known about its impact on socio‐economic outcomes.ObjectivesTo examine the association between acne and educational, labour market and relationship outcomes.MethodsWe conducted a nationwide registry‐based cohort study in Denmark. We included birth cohorts from 1982 to 1988 and compared those with
-
Risankizumab efficacy and safety in psoriatic patients with latent tuberculosis infection: A multicentric real‐world study J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-09-13 Annunziata Raimondo, Paolo Amerio, Anna Balato, Francesco Cusano, Maria Concetta Fargnoli, Claudio Guarneri, Luigi Ligrone, Matteo Megna, Maria Letizia Musumeci, Rosa Valentina Puca, Maria Teresa Uzzauto, Serena Lembo
-
Anti‐IL‐23 therapy for the treatment of moderate‐to‐severe inverse psoriasis: A 52‐week multicentre study J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-09-13 Joan Ceravalls, Ricardo Ruiz‐Villaverde, Susana Armesto, Josep Manel Fernández‐Armenteros, Josep Riera‐Monroig, Tamara Gracia‐Cazaña, Mònica Quintana‐Codina, Maribel Iglesias‐Sancho, Montserrat Salleras, Adrián Imbernón Moya, Francisco Javier Melgosa Ramos, Marta Ferran
-
Efficacy of dupilumab against pruritus in dystrophic epidermolysis bullosa: Real‐life data from a retrospective bicentric study J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-09-13 Christine Chiaverini, Stéphane Kandemir, Thomas Hubiche, Emmanuelle Bourrat, Alain Hovnanian
-
Acne and the cutaneous microbiome: A systematic review of mechanisms and implications for treatments J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-09-13 Alicia Podwojniak, Isabella J. Tan, John Sauer, Zachary Neubauer, Hanna Rothenberg, Hira Ghani, Aarushi K. Parikh, Bernard Cohen
Acne vulgaris is a pervasive skin disease characterized by inflammation of sebaceous units surrounding hair follicles. It results from the complex interplay between skin physiology and the intricate cutaneous microbiome. Current acne treatments, while effective, have major limitations, prompting a shift towards microbiome‐based therapeutic approaches. This study aims to determine the relationship between
-
The Dermatology Life Quality Index (DLQI) used as the benchmark in validation of 101 quality‐of‐life instruments: A systematic review J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-09-13 J. Vyas, J. R. Johns, Y. Abdelrazik, F. M. Ali, J. R. Ingram, S. Salek, A. Y. Finlay
BackgroundThe validation of psychometric measures requires use of other established and standardized validated measures. The Dermatology Life Quality Index (DLQI) is the most widely used tool to measure the burden of skin diseases and assess effectiveness of interventions based on patients' perspective.ObjectivesThe objective of this study was to systematically analyse peer‐reviewed publications describing
-
Impact of dermoscopy training associated with artificial intelligence on general practitioner residents J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-09-13 C. Dorado Cortez, A. Fakih, M. Bruet, E. Cinotti, L. Tognetti, J. L. Perrot
-
The development and validation of an investigator global assessment score for keratosis pilaris J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-09-13 Madeline A. Wang, Anna Wilson, Darby Boucher, Joslin S. Johal, Noy Keller Rosenthal, Timothy Cowan, Ben Koszegi, Alexis D. Lara Rivero, Benjamin S. Daniel, Linda K. Martin, Johannes S. Kern, Dedée F. Murrell
-
Advanced age and dermoscopic streaks increase the likelihood of a diagnostic upgrade of ambiguous melanocytic tumours after clinicopathological correlation J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-09-13 Emmanouil Chousakos, Zoe Apalla, Christina Nikolaidou, Matthaios Bobos, Aimilios Lallas
-
Concurrent intrathecal nivolumab and targeted therapy in a patient with melanoma‐associated leptomeningeal disease J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-09-12 Emma Chevallier, Violaine Flory, Madleen Chassang, Emma Huard, Fanny Burel‐Vandenbos, Thierry Passeron, Henri Montaudié
-
Abrocitinib for prurigo nodularis: Clinical efficacy and safety profile J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-09-12 Changchun Wang, Quanhong Zhang, Lang Yu, Liuqing Chen, Jinbo Chen
-
Large language models and dermoscopy: Assessing the potential of task‐specific GPT‐4 vision in diagnosing basal cell carcinoma J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-09-11 Daniele Omar Traini, Gerardo Palmisano, Ketty Peris
-
Hair regrowth in alopecia areata and re‐pigmentation in vitiligo in response to treatment: Commonalities and differences J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-09-11 Hiroki L. Yamaguchi, Yuji Yamaguchi, Elena Peeva
Both alopecia areata (AA) and vitiligo share common pathogenesis involving, interferon‐γ (IFN‐γ) and interleukin‐15 (IL‐15) signalling pathways that activate cytotoxic CD8+ T lymphocytes. These shared mechanisms may explain why both diseases respond to currently available treatments (e.g. topical/systemic corticosteroid) and emerging treatment modalities. As compared with the speed of re‐pigmentation
-
Extracorporeal photophoresis in treatment of corticosteroid refractory colitis induced by combined immunotherapy for metastatic melanoma J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-09-11 Marek Pásek, Jindřich Kopecký, Vojtěch Tretera, Petr Arenberger, Monika Arenbergerová
-
Paradoxical urticaria to H1‐antihistamines J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-09-10 Angèle Soria, Flore Kurihara, Emmanuelle Amsler, Alice Bréhon, Jean Eric Autegarden, Annick Barbaud
-
Assessing outcomes of cutaneous squamous cell carcinoma with large‐calibre nerve invasion as solitary high‐risk factor: A single‐institution cohort study J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-09-10 Nicole Loranger, Emily Karn, David Wang, Chrysalyne Schmults, Emily Ruiz
-
Skinformatics: Navigating the big data landscape of dermatology J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-09-10 Dorra Guermazi, Asghar Shah, Sara Yumeen, Terrence Vance, Elie Saliba
Big data and associated approaches to analyse it are on the rise, especially in healthcare settings. This growth is also seen with unique applications in the field of dermatology. While big data offer a plethora of opportunity for improving our current understanding of disease and ability to deliver care, as with any technology innovation, the potential pitfalls should be addressed. In this piece,
-
Predictors and mechanisms of self‐stigma in five chronic skin diseases: A systematic review J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-09-09 Caroline F. Z. Stuhlmann, Juliane Traxler, Valentina Paucke, Neuza da Silva Burger, Rachel Sommer
BackgroundPeople with skin disease suffer due to disease‐related physical symptoms, as well as due to significant psychosocial burden. A major contributor of this burden is the experience of stigmatization. Research indicates that people with visible skin diseases deal with both social stigma and self‐stigma.ObjectiveThis systematic literature review aimed to aggregate existing research on correlates
-
Real‐life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24‐week Italian study J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-09-09 B. M. Piraccini, F. Pampaloni, S. Cedirian, F. Quadrelli, F. Bruni, L. Rapparini, G. Caro, M. C. Acri, L. Ala, A. Rossi, G. Pellacani, F. Lacarrubba, G. Micali, F. Dall'Oglio, M. Vastarella, M. Cantelli, P. Nappa, L. Diluvio, L. Bianchi, L. Gnesotto, A. Sechi, L. Naldi, F. Tassone, K. Peris, G. Caldarola, L. M. Pinto, G. Girolomoni, F. Marangoni, F. Bellinato, P. Gisondi, I. Scandagli, F. Prignano
BackgroundAlopecia areata is an autoimmune condition characterized by rapid hair loss in the scalp, eyebrows and eyelashes, for which treatments are limited. Baricitinib, an oral inhibitor of Janus kinases 1 and 2, has been recently approved to treat alopecia areata.Materials and MethodsWe conducted a retrospective study involving 23 medical centres across Italy, enrolling patients affected by severe
-
Considerations for defining and diagnosing generalized pustular psoriasis J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-09-06 Vimal H. Prajapati, Charles W. Lynde, Melinda J. Gooderham, H. Chih‐ho Hong, Mark G. Kirchhof, Perla Lansang, Julien Ringuet, Irina Turchin, Ron Vender, Jensen Yeung, Kim A. Papp
Generalized pustular psoriasis (GPP) is a rare, chronic skin disease, characterized by widespread pustules and erythema, often accompanied with systemic signs and symptoms. GPP flares occur episodically but may be protracted. Left untreated, GPP can be life‐threatening. Despite being first reported over 100 years ago, definitions and diagnostic criteria for GPP have been inconsistent and varied due
-
Low‐dose isotretinoin for the management of rosacea: A systematic review and meta‐analysis J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-09-06 Aliyah King, Marcus G. Tan, Carly Kirshen, Stanislav N. Tolkachjov
BackgroundRosacea is a chronic, relapsing inflammatory dermatosis predominantly affecting the central face and can result in significant psychosocial impacts. Isotretinoin has been studied for rosacea due to its anti‐inflammatory and sebum reduction properties, but its use remains limited likely due to its off‐label use and potential adverse events.ObjectiveThis systematic review and meta‐analysis
-
Advances in image‐based diagnosis of nail disorders J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-09-04 Andrea Sechi, Ximena Wortsman, Antonella Tosti, Matilde Iorizzo
This paper provides a comprehensive overview of image‐based techniques, particularly focusing on their applications and advancements in the context of nail disorders. Nowadays, high‐resolution digital cameras and dermoscopes enable dermatologists to capture detailed images of nail abnormalities, facilitating early diagnosis and meticulous tracking of disease progression. Onychoscopy is now a routine
-
The risk of ultraviolet exposure for melanoma in Fitzpatrick skin types I–IV: A 20‐year systematic review with meta‐analysis for sunburns J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-09-04 Michael Kwa, Manisha Ravi, Kareem Elhage, Lonni Schultz, Henry W. Lim
Within the last two decades, no studies have comprehensively reviewed the risk of varying types of ultraviolet (UV) exposure on melanoma in fairer skinned individuals. Our research objective was to determine whether or not there was a change in the risk of UV exposure with development of melanoma in Fitzpatrick skin types I–IV based on more recent data over the past 20 years. We performed a systematic
-
BAUSSS biomarker improves melanoma survival risk assessment J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-08-31 Anthony J. Dixon, Howard K. Steinman, Alexander Nirenberg, Christos C. Zouboulis, Michael Sladden, Catalin Popescu, Stuart Anderson, Caterina Longo, J. Meirion Thomas
BackgroundThe American Joint Committee on Cancer (AJCC) method of staging melanoma is dated and inaccurate. It ignores important prognostic melanoma features, especially the patient's age. BAUSSS is more accurate in determining survival risk for primary cutaneous melanoma patients who have no clinical or imaging evidence of nodal or distant metastases. BAUSSS is an algorithm incorporating analysis
-
Weakly supervised deep learning image analysis can differentiate melanoma from naevi on haematoxylin and eosin‐stained histopathology slides J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-08-31 Nigel G. Maher, Homay Danaei Mehr, Cong Cong, Nurudeen A. Adegoke, Ismael A. Vergara, Sidong Liu, Richard A. Scolyer
BackgroundThe broad histomorphological spectrum of melanocytic pathologies requires large data sets to develop accurate and generalisable deep learning (DL)‐based diagnostic pathology classifiers. Weakly supervised DL promotes utilisation of larger training data sets compared to fully supervised (patch annotation) approaches.ObjectivesTo evaluate weakly supervised DL image classifiers for discriminating
-
Mobile teledermoscopy for patients at high risk of cutaneous melanoma: A single‐arm, feasibility study of a clinical intervention at two tertiary centres (MOBILEMEL) J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-08-29 Arthur Martin, Anne E. Cust, Serigne Lo, Rachael L. Morton, Nadine Kasparian, Helena Collgros, Natalie Teh, Linda Martin, Pascale Guitera
-
AI‐powered visual diagnosis of vulvar lichen sclerosus: A pilot study J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-08-28 Philippe Gottfrois, Jie Zhu, Alexandra Steiger, Ludovic Amruthalingam, Andre B. Kind, Viola Heinzelmann, Claudia Mang, Alexander A. Navarini, Simon M. Mueller
BackgroundVulvar lichen sclerosus (VLS) is a chronic inflammatory skin condition associated with significant impairment of quality of life and potential risk of malignant transformation. However, diagnosis of VLS is often delayed due to its variable clinical presentation and shame‐related late consultation. Machine learning (ML)‐trained image recognition software could potentially facilitate early
-
Familial Mediterranean fever and MEFV gene variants in hidradenitis suppurativa: A systematic review J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-08-27 Katherine Aw, Hillary A. Chan, Cathryn Sibbald, Vincent Piguet, David Croitoru
-
Will deciphering the epidermal ‘ménage à trois’ lead to predictive biomarkers for childhood atopic dermatitis? J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-08-23 Thomas Bieber
-
-
-
-
-
Atopic dermatitis and vitamin D supplementation: The end of the story? J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-08-23 C. Droitcourt, J. Arellano
-
Inherited ichthyoses patients: Individualized care and support urgently needed J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-08-23 Anna Zalewska‐Janowska, Adam Reich
-
Supportive oncodermatology is the key! J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-08-23 E. Parriel, V. Sibaud
-
-
Pharmacovigilance: The responsibility of all J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-08-23 Sarah Walsh
-
Prolonged complete remission of a lymphoepithelioma‐like carcinoma of the skin with bone metastases induced by pembrolizumab J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-08-22 Angèle Lallement, Quentin Samaran, Olivier Dereure, Aude Trinquet, Anouck Lamoureux
-
Excellent response to cemiplimab and radiotherapy in advanced metastatic porocarcinoma J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-08-22 Nessr Abu Rached, Vasileios Dervenis, Christina Scheel, Markus Stücker, Christian Baues, Cornelia Mauch, Martin Doerler
-
Melanosis and isolated follicular vitiligo during checkpoint inhibitors for metastatic melanoma J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-08-22 Valentine Salvestrini, Madleen Chassang, Nathalie Cardot‐Leccia, Manon Blaise, Thierry Passeron, Henri Montaudié
-
Recalcitrant erosive palms and soles eccrine syringofibroadenoma successfully treated with radiotherapy J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-08-22 Manon Blaise, Emma Huard, Nathalie Cardot‐Leccia, Jerome Doyen, Valentine Salvestrini, Henri Montaudié, Thierry Passeron
-
Erectile dysfunction in patients with seborrhoeic dermatitis J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-08-22 Corinne Rabbin‐Birnbaum, Keana Khodadad, Jill T. Shah, John G. Zampella
-
A randomized single‐blinded prospective study comparing simulated daylight photodynamic therapy with natural daylight photodynamic therapy for multiple actinic keratoses J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-08-22 C. Drumm, I. Morgan, A. Kavanagh, D. Gill, J. Buckley, M. Reade, E. Loughman, J. McCavana, A. Ryan, B. Moriarty, A. Lally
-
Langerhans cells: Central players in the pathophysiology of atopic dermatitis J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-08-19 Yi Pan, Mathias Hochgerner, Małgorzata Anna Cichoń, Theresa Benezeder, Thomas Bieber, Peter Wolf
Atopic dermatitis (AD) is the most common chronic inflammatory skin disease worldwide. AD is a highly complex disease with different subtypes. Many elements of AD pathophysiology have been described, but if/how they interact with each other or which mechanisms are important in which patients is still unclear. Langerhans cells (LCs) are antigen‐presenting cells (APCs) in the epidermis. Depending on
-
Epidermal proteomics demonstrates Elafin as a psoriasis‐specific biomarker and highlights increased anti‐inflammatory activity around psoriatic plaques J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-08-19 Anna Berekmeri, Tom Macleod, Isabel Hyde, Gregor Jan Ojak, Caroline Mann, Daniela Kramer, Martin Stacey, Miriam Wittmann
BackgroundEczema and psoriasis are common diseases. Despite both showing active epidermal contribution to the inflammatory process, their molecular aetiology and pathological mechanisms are different.ObjectiveFurther molecular insight into these differences is therefore needed to enable effective future diagnostic and treatment strategies. The majority of our mechanistic and clinical understanding
-
The Eczema Area and Severity Index: An update of progress and challenges in its measurement of atopic dermatitis after 20 years of use J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-08-19 M. E. Jacobson, R. Y. Morimoto, Y. A. Leshem, L. Howells, H. C. Williams, E. Grinich, L. A. A. Gerbens, P. I. Spuls, J. Schmitt, B. Staley, W. Baghoomian, N. Katoh, K. S. Thomas, C. J. Apfelbacher, E. L. Simpson
The Eczema Area and Severity Index is an investigator‐assessed instrument reporting clinical signs of atopic dermatitis. The instrument is extensively validated in both adult and paediatric populations and recommended as a core outcome measure to assess clinical signs by the Harmonising Outcome Measures for Eczema initiative in clinical trials and was recently recommended as an option to measure signs
-
Efficacy of interventions for cutaneous squamous cell carcinoma in situ (Bowen's disease): A systematic review and meta‐analysis of proportions J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-08-16 Anne Petzold, Anja Wessely, Theresa Steeb, Carola Berking, Markus V. Heppt
BackgroundCutaneous squamous cell carcinoma in situ (Bowen's disease) is a precancerous condition confined to the epidermis of the skin. Despite the critical need for effective interventions to halt its progression, there remains a notable shortage of comprehensive data comparing the efficacy of various therapeutic approaches.ObjectivesThis systematic review and meta‐analysis endeavour to compare the
-
Natural language processing in dermatology: A systematic literature review and state of the art J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-08-16 Alessia Paganelli, Marco Spadafora, Cristian Navarrete‐Dechent, Stefania Guida, Giovanni Pellacani, Caterina Longo
BackgroundNatural Language Processing (NLP) is a field of both computational linguistics and artificial intelligence (AI) dedicated to analysis and interpretation of human language.ObjectivesThis systematic review aims at exploring all the possible applications of NLP techniques in the dermatological setting.MethodsExtensive search on ‘natural language processing’ and ‘dermatology’ was performed on
-
Treatment of psoriasis with biologic and non‐biologic targeted therapies in patients with latent tuberculosis infection or at risk for tuberculosis disease progression: Recommendations from a SPIN‐FRT expert consensus J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-08-16 T. Torres, N. C. Brembilla, R. G. Langley, R. B. Warren, D. Thaçi, A. G. A. Kolios, J. C. Prinz, A. Londono‐Garcia, A. Nast, M. Santin, D. Goletti, M. Abreu, P. Spuls, W. H. Boehncke, L. Puig
Tuberculosis (TB), caused by Mycobacterium tuberculosis, is a significant global health problem. In immunocompetent individuals, the microorganism can remain in a latent, non‐contagious form, however, it may become active under conditions of immunosuppression. Tumour necrosis factor (TNF) inhibitors, which are frequently used for the management of immune‐mediated disorders like psoriasis, have been
-
Factors associated with long‐term complete remission in pemphigus patients receiving rituximab therapy J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-08-16 Hao‐Chen Hsu, Po‐Wei Huang, Yung‐Tsu Cho, Chia‐Yu Chu
-
Trending on TikTok: An analysis of melanotan content on social media J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-08-16 Maeve Herlihy, Stephanie Bowe, Kashif Ahmad
-
Happiness across the borders—A cross‐sectional study among patients with psoriasis and atopic dermatitis in Europe J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-08-14 S. Ziehfreund, H. Wecker, S. Mittag, J. Weis, L. Tizek, V. Verkhoturova, F. J. Legat, W. Weger, K. Großschädl, U. Cerpes, B. Sadoghi, M. Riegler, A. Balato, E. V. Di Brizzi, D. Buononato, G. Babino, P. Calzavara‐Pinton, M. T. Rossi, S. Rovaris, A. Dimech, M. J. Boffa, P. Chernyshov, T. Svyatenko, L. Kolodzinska, M. Sikora, T. Torres, L. Manolache, E. Scala, T. Biedermann, A. Zink
BackgroundDermatological research has traditionally concentrated on evaluating mental comorbidities, neglecting positive concepts like happiness. Initial studies indicate that psoriasis and atopic dermatitis (AD) impair the happiness of those affected. Considering global happiness variations, this study aimed to explore the disease‐ and country‐specific differences in disease‐related quality of life
-
Cutaneous leishmaniasis as immune reconstitution syndrome: A clinical and histopathological case series J. Eur. Acad. Dermatol. Venereol. (IF 8.4) Pub Date : 2024-08-13 Anne‐Emmanuelle Luce, Kinan Drak Alsibai, Camille Thorey, Blandine Guttierez, Magalie Demar, Romain Blaizot, Geoffrey Grotta